Navigation

Glaucoma

Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension

Status: History
Publication date: April 2009
Wave: 12
Process: CG
Topic area:
  • Eye
  • Surgical procedures
 

NICE project team

Centre for clinical practice lead: Andrew Dillon
Communications manager: Adrian Ward
Guidelines commissioning manager: Sarah Willett
Guidelines coordinator: Andrew Gyton
Patient involvement lead: Victoria Thomas
Guidelines Development Group: The Guideline Development Group (GDG) oversees the development process.
Top


Email enquiries

If you have any queries please email nice@nice.org.uk
Top


 

Provisional schedule

Scoping workshop: 05 March 2007
Consultation on draft scope with stakeholders: 26 February - 26 March 2007
Consultation on draft guideline with stakeholders: 29 Sept 08 – 24 Nov 08
Pre-publication check: TBC
Publication date: April 2009
Top


 

Project history

Date Update
10 February 2006

The remit for this guideline was received from the Department of Health and the Welsh Assembly Government in November 2005 as part of the Institute's 12th wave work programme.

See below for more information on the Institute's guideline development process.

26 February 2007 The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed above, by the deadline shown.
27 March 2007 Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply.
26 July 2007 The scope defines what aspects of care are covered by the guideline and to whom it applies.
26 February 2008

Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table.

The Guideline Development Group (GDG) oversees the development process. See a list of GDG members.

The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It  will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG. 

Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline.  Please see timescales for dates of consultation with stakeholders.

1 April 2009 Responsibility for the development of this guideline has transferred to the National Clinical Guidelines Centre for Acute and Chronic Conditions. Key contacts and timelines remain unchanged.
Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.